Shares of Biocon saw a significant surge of over 7 percent on Tuesday, January 14, 2025, following an upgrade by global brokerage firm HSBC. The firm raised its rating on the stock to ‘Buy’ and set a ...

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg ...

Biocon Limited ( ($IN:BIOCON) ) has issued an update. Biocon Limited has significantly increased its stake in its unlisted material subsidiary, ...